Clinical Trial Update: Randomized Study of Intravenous Immunoglobulin (IVIg) in Patients With Subacute Proximal Diabetic Neuropathy [NA]

View source ↗

Summary

The clinical trial evaluating intravenous immunoglobulin (IVIg) for subacute proximal diabetic neuropathy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Mayo Clinic | Conditions: Diabetic Neuropathies | NA | Status: TERMINATED